Alembic Pharmaceuticals informs about appointment of non-executive non-independent director
Alembic Pharmaceuticals has informed that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors, the Shareholders of the Company vide Postal Ballot dated 31st March, 2026, approved the appointment of Rajkumar Baheti (DIN: 00332079) as Non-Executive Non-Independent Director, liable to retire by rotation with effect from 1st April, 2026. In this regard, the company has declared that Rajkumar Baheti is not debarred from holding the office of Director by virtue of any SEBI order or any other such authority. The details as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 is attached as ‘Annexure-A’.
The above information is a part of company’s filings submitted to BSE.
